Browsing byAuthorPryor, D

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)
2018Development of Indicators to Assess Quality of Care for Prostate CancerNag, N; Millar, J; Davis, ID; Costello, S; Duthie, JB; Mark, S; Delprado, W; Smith, D; Pryor, D; Galvin, D; Sullivan, F; Murphy, Á; Roder, D; Elsaleh, H; Currow, D; White, C; Skala, M; Moretti, KL; Walker, T; De Ieso, P; Brooks, A; Heathcote, P; Frydenberg, M; Thavaseelan, J; Evans, SM
2021-08-29Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II)Siva, S; Bressel, M; Mai, T; Le, H; Vinod, S; de Silva, H; Macdonald, S; Skala, M; Hardcastle, N; Rezo, A; Pryor, D; Gill, S; Higgs, B; Wagenfuehr, K; Montgomery, R; Awad, R; Chesson, B; Eade, T; Wong, W; Sasso, G; De Abreu Lourenco, R; Kron, T; Ball, D; Neeson, P; Bettington, C; Cook, O; Foote, M; Gowda, R; Haas, M; Haynes, NM; Hilder, B; Lao, L; Lim, A; Ludbrook, J; Jansen, T; MacManus, M; McCullough, SA; Moore, A; Ritchie, D; Shaw, M; Sia, J; Syed, F; Tang, C; Trapani, J
2021-05-03Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoringLee, YYD; Nguyen, DT; Moodie, T; O’Brien, R; McMaster, A; Hickey, A; Pritchard, N; Poulsen, P; Tabaksblat, EM; Weber, B; Worm, E; Pryor, D; Chu, J; Hardcastle, N; Booth, J; Gebski, V; Wang, T; Keall, P
2018-10-23TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II 11 Medical and Health Sciences 1103 Clinical Sciences 11 Medical and Health Sciences 1112 Oncology and CarcinogenesisSiva, S; Chesson, B; Bressel, M; Pryor, D; Higgs, B; Reynolds, HM; Hardcastle, N; Montgomery, R; Vanneste, B; Khoo, V; Ruben, J; Lau, E; Hofman, MS; De Abreu Lourenco, R; Sridharan, S; Brook, NR; Martin, J; Lawrentschuk, N; Kron, T; Foroudi, F